On April 6, 2023, Karin Eastham informed the Board of Directors (the Board") of Nektar Therapeutics (the
Company") that she has elected not to stand for re-election and will complete her term on the Board at the
conclusion of the Company's 2023 annual meeting of stockholders. Ms. Eastham's decision not to stand for
re-election was not due to a disagreement with the Company on any matter relating to the Company's operations,
policies, or practices.